• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

BCG in Immunocompromised Patients: Is it effective? Is it safe?

作者信息

Messing Edward M

机构信息

University of Rochester Medical Center, Rochester, NY, USA.

出版信息

Bladder Cancer. 2024 Mar 12;10(1):89-91. doi: 10.3233/BLC-249001. eCollection 2024.

DOI:10.3233/BLC-249001
PMID:38993531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11181704/
Abstract
摘要

相似文献

1
BCG in Immunocompromised Patients: Is it effective? Is it safe?卡介苗在免疫功能低下患者中的应用：它有效吗？安全吗？
Bladder Cancer. 2024 Mar 12;10(1):89-91. doi: 10.3233/BLC-249001. eCollection 2024.
2
Case Report: Disseminated, rifampicin resistant (BCG) infection in an immunocompromised child.病例报告：一名免疫功能低下儿童发生播散性耐利福平（卡介苗）感染。
Wellcome Open Res. 2020 Oct 15;5:242. doi: 10.12688/wellcomeopenres.16280.1. eCollection 2020.
3
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer.免疫功能低下的膀胱癌患者膀胱内卡介苗。
BJU Int. 2013 May;111(6):984-7. doi: 10.1111/j.1464-410X.2012.11778.x. Epub 2013 Jan 25.
4
Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population.在卡介苗接种人群中，免疫功能低下患者的结核菌素皮肤试验和干扰素-γ释放试验在检测结核感染方面的表现。
BMC Infect Dis. 2009 Dec 15;9:207. doi: 10.1186/1471-2334-9-207.
5
Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis.阳离子脂质体构建牛分枝杆菌 mmaA4 基因缺失突变株显著增强抗结核保护作用。
PLoS One. 2012;7(3):e32959. doi: 10.1371/journal.pone.0032959. Epub 2012 Mar 19.
6
Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.2010 - 2017年新发现的原发性免疫缺陷病中的卡介苗并发症
Front Immunol. 2018 Jun 22;9:1423. doi: 10.3389/fimmu.2018.01423. eCollection 2018.
7
Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation.脐带血干细胞移植后膀胱原位癌卡介苗的安全有效给药。
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12758. Epub 2017 Sep 25.
8
BCG-itis in two antiretroviral-treated HIV-infected infants.两名接受抗逆转录病毒治疗的HIV感染婴儿发生卡介苗病。
Int J STD AIDS. 2010 Sep;21(9):662-3. doi: 10.1258/ijsa.2010.010267.
9
Mycobacterium bovis endophthalmitis from BCG immunotherapy for bladder cancer.卡介苗免疫疗法治疗膀胱癌引发的牛分枝杆菌眼内炎
Ocul Immunol Inflamm. 2008 May-Jun;16(3):95-7. doi: 10.1080/09273940802056273.
10
Do higher cut-off values for tuberculin skin test increase the specificity and diagnostic agreement with interferon gamma release assays in immunocompromised Bacillus Calmette-Guérin vaccinated patients?在接种卡介苗的免疫功能低下患者中，结核菌素皮肤试验的更高临界值是否会提高其特异性以及与干扰素γ释放试验的诊断一致性？
Adv Med Sci. 2018 Sep;63(2):237-241. doi: 10.1016/j.advms.2017.12.001. Epub 2018 Feb 8.

本文引用的文献

1
Bacillus Calmette-Guerin (BCG) therapy is safe and effective in non-muscle invasive bladder cancer (NMIBC) patients with immunomodulating conditions.卡介苗（BCG）治疗在具有免疫调节条件的非肌肉浸润性膀胱癌（NMIBC）患者中是安全有效的。
Urol Oncol. 2024 Jan;42(1):21.e21-21.e28. doi: 10.1016/j.urolonc.2023.09.010. Epub 2023 Oct 16.
2
Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy.病例报告：血液恶性肿瘤后免疫重建延迟背景下的获得性播散性卡介苗感染。
Front Immunol. 2021 Aug 3;12:696268. doi: 10.3389/fimmu.2021.696268. eCollection 2021.
3
A 25-year surveillance of disseminated Bacillus Calmette-Guérin disease treatment in children in Southern Iran.伊朗南部儿童播散性卡介苗病治疗的25年监测
Medicine (Baltimore). 2017 Dec;96(52):e9035. doi: 10.1097/MD.0000000000009035.
4
Failure of Bacillus Calmette-Guérin therapy in non-muscle-invasive bladder cancer: Definition and treatment options.卡介苗治疗非肌层浸润性膀胱癌失败：定义及治疗选择
Arch Esp Urol. 2016 Sep;69(7):423-33.
5
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.非肌肉浸润性膀胱癌的诊断与治疗：AUA/SUO 指南。
J Urol. 2016 Oct;196(4):1021-9. doi: 10.1016/j.juro.2016.06.049. Epub 2016 Jun 16.
6
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.非肌层浸润性膀胱癌的定义、终点指标及临床试验设计：国际膀胱癌小组的建议
J Clin Oncol. 2016 Jun 1;34(16):1935-44. doi: 10.1200/JCO.2015.64.4070. Epub 2016 Jan 25.
7
The mechanism of action of BCG therapy for bladder cancer--a current perspective.BCG 疗法治疗膀胱癌的作用机制——当前的观点。
Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4.
8
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer.免疫功能低下的膀胱癌患者膀胱内卡介苗。
BJU Int. 2013 May;111(6):984-7. doi: 10.1111/j.1464-410X.2012.11778.x. Epub 2013 Jan 25.
9
Management of bladder cancer after renal transplantation.肾移植后膀胱癌的管理。
Urology. 2013 Apr;81(4):813-9. doi: 10.1016/j.urology.2012.11.035. Epub 2013 Jan 3.
10
Management of Bladder Cancer following Solid Organ Transplantation.实体器官移植后膀胱癌的管理
Adv Urol. 2011;2011:256985. doi: 10.1155/2011/256985. Epub 2011 Apr 18.